Article Name Clinical & Diagnostic

Beckman Coulter's DxC 500 AU Chemistry Analyzer Receives FDA Clearance

Beckman Coulter Diagnostics, a clinical diagnostics leader, received FDA clearance for its new DxC 500 AU Chemistry Analyzer, an automated chemistry analyzer, expanding the company's clinical chemistry offering and demonstrating ongoing commitment to product innovation in the in vitro diagnostic industry. Designed for small-to-medium-sized laboratories, the DxC 500 AU Chemistry Analyzer is one of several recent Beckman Coulter solutions designed to optimize laboratory workflows and support critical clinical decisions.

26th July, 2023


Fractus expands into healthcare with wireless implantable device technology

Fractus' groundbreaking antenna technology now ventures into the realm of healthcare. The company has successfully developed an innovative wireless implantable device technology, revolutionizing the way doctors remotely monitor their patients and boosting the uptake of telehealth services by leveraging wireless connectivity. With the ability to offer real-time data and feedback, this cutting-edge technology is set to greatly improve patient care, enabling doctors to make timely, informed decisions and fostering personalized consultations that actively engage patients in their treatment journeys.

25th July, 2023


Apollo Dominates Global Multi-Organ Transplants with 23,000+ Procedures

Apollo leads India's Solid Multi-Organ Transplantation with over 23000 transplants, establishes global leadership

25th July, 2023


Nesa Medtech gets US FDA clearance for fibroid mapping reviewer application

Novel SaMD technology generates a 3D model of uterus to facilitate treatment in patients with symptomatic uterine fibroids

25th July, 2023


BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that the updated BD Alaris™ Infusion System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), which enables both remediation and a return to full commercial operations for the most comprehensive infusion system available in the United States.

24th July, 2023


AACC Rebrands to the Association for Diagnostics & Laboratory Medicine

Association mission remains the same—better health through laboratory medicine.

24th July, 2023


UroMems Announces First-Ever Smart Artificial Urinary Sphincter Implant in a Female Patient

Initial clinical study results will inform pivotal clinical trial in U.S. and Europe

21st July, 2023


Lark Health and Desert Oasis Healthcare Announce Expanded Partnership

Lark Health, the leading AI-powered digital care coaching company for the prevention and management of chronic conditions, and Desert Oasis Healthcare (DOHC), a member of Heritage Provider Network, today announced their expanded partnership where DOHC will offer Lark's Prevention program and CDC-recognized Diabetes Prevention program to their patients.

21st July, 2023


Verantos' AI Advancement in Neurology Bolstered by Groundbreaking Migraine Real-World Evidence

Technology enables inference of subjective outcomes from routinely collected data

20th July, 2023


Vial Enrolls First Patient in "OcuCool" Precision Cooling Trial Sponsored by RecensMedical

Vial, a leading global contract research organization (CRO) providing next-generation clinical trial management services, announced the enrollment of the first patient in the pivotal clinical trial, "COOL-3s", evaluating the OcuCool system, developed by RecensMedical, Inc. ("RecensMedical"), a distinguished medical device company based in South Korea.

20th July, 2023


Hackensack Meridian JFK University Medical Center Performs First Robotic Surgery with Heated Chemotherapy for Malignant Thymoma

Surgeons in the Division of Thoracic Surgery at JFK University Medical Center first in the State of New Jersey to perform this surgery

19th July, 2023


Improved Access to Alzheimer's Blood Test Through Beckman Coulter-Fujirebio Partnership

Collaboration Builds upon Fujirebio Expertise in Neurodegenerative Disease Assays and Beckman Coulter’s High Sensitivity, High Throughput, Global Installed Base of Access Family of Immunoassay Analyzers

18th July, 2023


Devyser's NGS Products for Kidney Transplants Get IVDR Approvals

Devyser's novel test for detecting donor-derived cell-free DNA in blood samples from kidney-transplant patients and its product for screening and follow-up of stem cell transplanted patients fulfill IVDR requirements in Europe. These tests are the first post-transplant monitoring NGS products to be approved under the new, more comprehensive regulation that came into force in May 2022 and confirm Devyser's two NGS products meet the established safety, efficacy, and quality requirements.

18th July, 2023


Optina's REPHRASE Study Validates Innovative Alzheimer's Test

Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr™-Cerebral Amyloid Status (CAS) test, an innovative tool intended to provide physicians with definitive information about Alzheimer's pathology, enabling improved management of cognitive impairments.

18th July, 2023


Pluss Advanced Technologies enhances availability of neonatal cooling device 'MiraCradle'

UK-based The Rodnight Partnership ties up with India's Pluss

18th July, 2023


Kidney Patients Expand Worldwide Impact on Medical Innovations

Patient-Led Global Summit on Science, Policy, and Care Choice Drives Optimism

17th July, 2023


Aster DM Healthcare Successfully Rebrands Ramesh Hospitals to Aster Ramesh Hospitals

Affirms Strong Performance and Focus on India Amidst Ongoing Expansion

17th July, 2023


Yashoda Hospital, Kaushambi forays into genomic testing in collaboration with HaystackAnalytics

Brings Delhi’s first-ever comprehensive preventive health solution called Smart Gene Plan

17th July, 2023


Medtech Special

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer